MedPath
FDA Approval

Tobramycin and Dexamethasone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 31, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tobramycin(3 mg in 1 mL)
Dexamethasone(1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bausch & Lomb Incorporated

Bausch & Lomb Incorporated

079587625

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin and Dexamethasone

Product Details

NDC Product Code
24208-295
Application Number
ANDA064134
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
August 31, 2023
TYLOXAPOLInactive
Code: Y27PUL9H56Class: IACT
Code: VZ8RRZ51VKClass: ACTIBQuantity: 3 mg in 1 mL
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)Inactive
Code: S38J6RZN16Class: IACT
Code: 7S5I7G3JQLClass: ACTIBQuantity: 1 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM SULFATEInactive
Code: 0YPR65R21JClass: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCFClass: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
© Copyright 2025. All Rights Reserved by MedPath